Sano Genetics | Latest News & Updates - Apr 09, 2025 Release

Anthony Kayas has joined Sano Genetics as Director of Commercial Enterprise Accounts, previously serving as Account Manager - US East at Newcells Biotech Ltd in the United States...


Brought to you by RivalSense - an AI tool for monitoring any company.

RivalSense tracks the most important product launches, fundraising news, partnerships, hiring activities, pricing changes, tech news, vendors, corporate filings, media mentions, and other developments of companies you're following 💡


Sano Genetics

🌎 sanogenetics.com

Sano Genetics is a biotechnology research company based in Cambridge, England, focused on accelerating the transition to precision medicine. The company offers an end-to-end precision medicine platform that integrates genetic testing, recruitment, and long-term patient engagement, streamlining clinical operations and enhancing the efficiency of clinical trials.


Sano Genetics - Latest News and Updates

  • Anthony Kayas has joined Sano Genetics as Director of Commercial Enterprise Accounts, previously serving as Account Manager - US East at Newcells Biotech Ltd in the United States.
  • Sano Genetics' leadership and extended-leadership teams recently held in-person meetings and will attend the World Orphan Drug Congress in Boston on April 22-24.
  • Paul Wicks, Vice President of Neuroscience at Sano Genetics, is attending AD/PD 2025 in Vienna to discuss advances in Alzheimer's and Parkinson's disease.
  • Sano Genetics is an early adopter of the We Show the Salary pledge, promoting salary transparency in job ads for over two years.

Sign up to receive regular updates


If you liked the insights, consider following your own companies of interest. Receive weekly insights directly to your inbox using RivalSense.